The National Science Foundation Division of Industrial Innovation awarded a $256,000 Project Grant to develop an automatic debridement device from August 1, 2021 through March 31, 2022. This Small Business Innovation Research Phase I award under the Engineering (47.041) program will support the creation of a product to automatically remove dead, damaged, or infected tissue. The NSF Directorate for Engineering seeks to foster innovation and excellence in engineering research, consistent with...
The National Science Foundation awarded Winter Innovations, Inc. a $256,000 Project Grant under the NSF Technology, Innovation, and Partnership's SBIR PHASE I program. The award period runs from May 1, 2021 to June 30, 2022 and supports the development of a novel suturing device. The NSF SBIR PHASE I program aims to advance science, engineering, and technology innovations through funding early-stage research and development of technologies with promising commercial potential. Under this award,...
The National Science Foundation awarded a $255,731 Small Business Innovation Research Phase I Project Grant to Senoguard Inc. under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084). The grant funds the development and preclinical testing of a novel cryoablation probe system for post-lumpectomy margin ablation cancer treatment. Specifically, the company will design and optimize the probe for optimal contact and thermal transfer with tumor cells in fixed in vitro testing. The...
This National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I Project Grant award of $275,000 to Surgic, LLC, located in Amarillo, TX, is for the development of a customizable surgical training platform supported by artificial intelligence. The project aims to improve the realism of recreated patient anatomy and enable scenario customization during surgical training using 3D printing, mechanical testing, and machine learning techniques. The platform will provide...
This $254,456 Small Business Innovation Research (SBIR) Phase I federal grant award from the National Science Foundation (CFDA 47.084 - NSF Technology, Innovation, and Partnerships program) supports the development of a novel, multifunctional neural probe called the "Neurobionics Omnifiber" by Neurobionics Inc. The key objectives are to integrate electrical, optical, and chemical capabilities into a single implantable device for neuroscience research. This versatile tool will enable...
This Cooperative Agreement award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) provides $1,000,000 in funding to Winter Innovations, Inc. to develop a novel suturing device for orthopedic ligament and tendon surgical procedures. The innovation utilizes a two-part needle technology to improve surgical consistency, reduce procedure times by one-third, and decrease revision rates by nearly two-thirds compared to current...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award of $999,545 to Senoguard Inc., a woman-owned small business located in Seal Beach, CA, is supporting the development and testing of a novel minimally invasive cryogenic probe for post-lumpectomy margin ablation treatment. The project aims to complete engineering and validation activities for this cryoablation probe, which will be coupled with an external cryoagent controller,...
Revmedica Inc. received a $275,881 Small Business Innovation Research Phase I Project Grant from the National Science Foundation on May 1, 2021 to develop a hybrid surgical stapler with tissue sensing technology. The NSF Engineering Division grant program supports innovative engineering research and development with the goal of improving quality of life and U.S. economic strength. Under this award, Revmedica will leverage tissue sensing capabilities to enhance surgical stapling devices used in...
This $274,990 Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) supports the development of a novel optical method for detecting microscopic tumors to enable more rapid and accurate point-of-care cancer diagnoses. The project aims to integrate plasmonic nanobubble sensors into a medical device platform and endoscope to perform minimally invasive, non-invasive cancer diagnostic procedures. The key product being...
The National Science Foundation (NSF) awarded a $275,000 Small Business Innovation Research (SBIR) Phase I project grant to Agil Therapeutics Inc. under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084). This two-year project aims to develop a novel cryoablation system for minimally invasive treatment of type 2 diabetes. The system is designed to deliver a highly controlled and targeted cryogenic agent to the duodenum, with the goal of remodeling the duodenal tissue to...